Please provide your email address to receive an email when new articles are posted on . Among pediatric patients in the Pediatric Pulmonary Hypertension Network, nearly half had group 3 disease, ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello, and welcome to this podcast series. I'm Dr Vallerie McLaughlin, the Kim A. Eagle Endowed Professor of Cardiovascular ...

Pulmonary hypertension is high blood pressure in the arteries of your lungs. These arteries carry blood from the heart to the lungs and when the walls of the arteries get thick, it narrows the space ...

Investigators provide recent information on the classification, pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension, focusing specifically on its impact on women. Pulmonary ...

Advanced imaging, like 4D-flow CMR, aids in understanding PA remodeling in different PH subtypes, offering non-invasive differentiation. PAH patients exhibit distinct PA flow characteristics, ...

High blood pressure can indirectly cause shortness of breath by forcing the heart to work harder, which may lead to cardiovascular issues. Pulmonary hypertension, a specific type of high blood ...

Pulmonary hypertension risk increases with the severity of CKD, and affects up to two-thirds of patients receiving hemodialysis.

Irregular heart rhythms are common in PAH and tied to higher risk of poor outcomes, with right heart changes helping predict ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.